Today, Folia Health and Novartis Pharmaceuticals, Inc. proudly announce their collaboration on an innovative, at-home ...

Novartis has announced the beginnings of a major cardiovascular outcomes trial in the UK, an event seized upon by politicians as evidence that the country is a world leader in pharma R&D.

The National Football League has signed its first-ever pharmaceutical partner in a multi-year deal with Switzerland-based ...

Novartis has revealed that it may be closing its UK site in Horsham, West Sussex, putting 371 jobs and 170 local contractors at risk. Plus, the company announced it was proposing to withdraw ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Dr Parker said that the British chemistry community is resting its hopes on the current reshaping of the UK pharmaceuticals industry which has been developing a different profile since 2011 when ...

Novartis' dividend yield currently stands at 3.58%, which is significantly higher than that of the healthcare sector. Read ...

Novartis has brought abelacimab back into the fold. Six years after spinning the asset out to form Anthos Therapeutics, Novartis has struck a deal to buy Anthos for $925 million upfront to add the ...